Do I need a new consent form for every refill?

No. A new form is typically only required if the medication class changes or the pharmacy source shifts.

What happens if a patient refuses to sign the compound disclosure?

The clinic should not dispense or prescribe the compounded medication. Without documented consent, the provider assumes all liability for adverse events.

Is a verbal agreement sufficient for compounding?

No. Verbal consent is not legally defensible in medical malpractice or regulatory audits. Always use written or digital documentation.

Compliance

Patient Consent Protocols for Compounded Medications

Published August 9, 2026 · 5 minutes

Prescribing compounded medications requires more than a standard intake form. Patients must understand that these drugs are not FDA-approved in the same way as their commercial counterparts. Clinics that fail to document this specific acknowledgment face significant legal and regulatory risks. This guide outlines the necessary components of a compliant consent process for peptides and GLP-1s.

Defining Informed Consent for Compounds

Informed consent is a legal process where a patient agrees to a treatment after understanding the risks and benefits. For compounded drugs, the burden of proof rests on the provider to show the patient knew they were receiving a non-branded medication.

Clearly state the medication is made in a compounding pharmacy.
Explain that the specific formulation is not FDA-approved.
List all potential side effects and contraindications.
Document the medical necessity for choosing a compound.
Record the date and time of the signed agreement.

Required Disclosure Elements

Your consent forms should avoid vague language. Regulators look for specific disclosures regarding the source of the medication and the lack of a generic equivalent status for new GLP-1s.

The name and location of the compounding pharmacy.
A statement that the pharmacy is state-licensed or a 503B facility.
Confirmation that the drug contains the same active ingredient as the brand name.
Acknowledgment that the medication is not commercially manufactured.

Managing Patient Expectations

Patients often confuse compounded GLP-1s with brand-name versions like Ozempic or Mounjaro. Your consent process must clarify these differences to prevent future disputes.

Digital vs Paper Documentation

Electronic health records provide better protection than paper files. Digital signatures create a verifiable audit trail that is difficult to challenge in court.

Use HIPAA-compliant software for all signatures.
Store copies of the consent form in the patient portal.
Update consent forms whenever the dosage or pharmacy changes.
Ensure the medical director reviews all high-risk consents.

Training Your Clinical Staff

Consistency is vital. Every staff member who interacts with the patient must deliver the same message regarding the nature of compounded therapy. Inconsistent verbal communication can invalidate a written consent form.

FAQs

Do I need a new consent form for every refill?: No. A new form is typically only required if the medication class changes or the pharmacy source shifts.
What happens if a patient refuses to sign the compound disclosure?: The clinic should not dispense or prescribe the compounded medication. Without documented consent, the provider assumes all liability for adverse events.
Is a verbal agreement sufficient for compounding?: No. Verbal consent is not legally defensible in medical malpractice or regulatory audits. Always use written or digital documentation.

Launch your white-label program

Apply to Direct Peptide Sales, most practices onboard inside 30 days.

Apply now →